Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Huntingtin (HTT) (N-Term) Peptid

HTT Reaktivität: Human Wirt: Synthetic WB, BP
Produktnummer ABIN5671637
  • Target Alle Huntingtin (HTT) Produkte
    Huntingtin (HTT)
    Protein Region
    N-Term
    Spezies
    Human
    Quelle
    • 2
    Synthetic
    Applikation
    Western Blotting (WB), Blocking Peptide (BP)
    Sequenz
    QQQQQQQQQQ QQQQQQQQQP PPPPPPPPPP QLPQPPPQAQ PLLPQPQPPP
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti- HTT Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Huntingtin (HTT)
    Hintergrund
    Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression.

    Alias Symbols: HD, IT15

    Protein Size: 293
    Gen-ID
    3064
    NCBI Accession
    NM_002111, NP_002102
Sie sind hier:
Kundenservice